glp 1 agonist inflammation Anti-inflammatory role of glucagon-like peptide receptor agonists and its clinical implications The anti-inflammatory and immunological properties
Description
doi: 10.3390/pharma3040025
Secher, A
That approval for Type 1 diabetes is important because it is something no GLP-1 medication can claim
A tale of two giants Novo Nordisk and Eli Lilly have long been titans in the diabetes care sector, and now they're both carving out new growth narratives in the obesity treatment market
